POGMENT Biomimic Collagen Reacquired Recognition, Founder Appointed as Industrial Mentor for Master’s Students at East China Normal University, Awarded 2025 Innovation Leadership Award
CHENGDU, China, Dec. 31, 2025 /PRNewswire/ -- On December 27, the 2025 Master of Engineering Management (MEM) Industry Mentor Orientation and Appointment Ceremony was held at the Wenshi Building on the Putuo Campus of East China Normal University (ECNU), located at No. 3663 Zhongshan North Road, Putuo District, Shanghai. Professor He Jiaxun, Professor and Doctoral Supervisor at East...
KLMBio Accelerates Global Expansion in Bone Graft Market with Human Tissue-Based Medical Devices
SEOUL, South Korea, Dec. 31, 2025 /PRNewswire/ -- KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its high-value tissue-based product portfolio to target the rapidly growing global bone graft market. The global bone graft market is a high-growth medical device sector, driven by steadily increasing usage in orthopedic surgery, spinal...
Entering the New Year, VARON Strengthens Commitment to Dependable Oxygen Support
NEW YORK, Dec. 31, 2025 /PRNewswire/ -- As the new year begins, it offers a meaningful moment to reflect on shared progress and renewed responsibility in respiratory care. Over the past year, VARON has continued to focus on what matters most—reliability, accessibility, and compassion-driven action that supports real people and real needs. A...
Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 monoclonal antibody (R&D code: 9MW3811) for pathological scarring recently completed the first patient dosing in China, becoming the world's first IL-11 targeting drug candidate to initiate clinical trials for...
China’s Sleep Technology Pioneer Sleemon Draws Increasing Interest from the Global AI Community
SHAOXING, China, Dec. 30, 2025 /PRNewswire/ -- A long-established household brand in China with a comparatively limited international profile, Sleemon Healthy Sleep Technology Co., Ltd. is gaining attention from the global technology community as it expands its focus on advanced sleep technology solutions. Founded in 1984, Sleemon was the first mattress manufacturer in China to list publicly (SSE:...
The “Eastern Wisdom” of Aging: How Taikang’s “New Life Insurance” Responds to a Global Challenge?
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Under the global background of ageing people, WallstreetCN reported how TaiKang play its wisdom in new-life-insurance. In 2014, journalists from Japan's NHK documented the phenomenon of A Society Without Bonds, portraying how the elderly in an atomized society—devoid of social, familial, or community ties—gradually become isolated and ultimately pass away alone. A decade later,...
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, becoming the first AI-driven biotech company to go public in Main Board under Chapter 8.05 listing rules of the HKEX. This initial public offering (IPO) raised...
Dr. Lu Xianping, Founder, Chairman of Chipscreen Biosciences named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards
SHENZHEN, China, Dec. 30, 2025 /PRNewswire/ -- On December 5, 2025, Dr. Lu Xianping, Founder, Chairman of Shenzhen Chipscreen Biosciences Co., Ltd, has been named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards. Dr. Lu Xianping delivers his remarks at the award ceremony. This recognition honors his outstanding contributions to advancing new-quality...
Bioelectric Toothbrush Offers New Approach with 6x Plaque Removal
Clinically validated microcurrent technology now available in the U.S. market SAN FRANCISCO, Dec. 29, 2025 /PRNewswire/ -- Great Gums Inc. today announced the U.S. launch of its bioelectric toothbrush, a clinically validated oral care device that delivers safe microcurrents to remove plaque from hard-to-reach areas where traditional bristles cannot effectively clean. Great Gums bioelectric toothbrush...
HKSH Medical Group and Southern University of Science and Technology Collaborate for Medical and Medical Physics Training, Enhancing Medical Education and Research Innovation
HONG KONG, Dec. 29, 2025 /PRNewswire/ -- HKSH Medical Group ("HKSH") and Southern University of Science and Technology ("SUSTech") officially signed a Memorandum of Understanding ("MOU") on 15 December 2025, a significant initiative to deepen collaboration between Hong Kong and the Chinese Mainland in the fields of medicine and medical physics. During the ceremony, Dr. Walton LI, Chief...
